Cover Image
市場調查報告書

疤痕增長症:全球臨床實驗檢討

Keloids Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 296478
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
疤痕增長症:全球臨床實驗檢討 Keloids Global Clinical Trials Review, H2, 2017
出版日期: 2017年11月22日 內容資訊: 英文 58 Pages
簡介

本報告提供疤痕增長症的臨床研究最新趨勢相關分析,以疾病概要為首,提供G7各國·E7各國的臨床實驗狀況,各地區、各階段的進行狀況,受驗者的募集情況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

目錄

簡介

  • 疤痕增長症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 臨床實驗數量亞太地區的主要5個國家
    • 臨床實驗數量歐洲的主要5個國家
    • 北美的主要國家臨床實驗數量
    • 中東·非洲的主要國家臨床實驗數量
    • 中南美的主要國家臨床實驗數量

在G7各國臨床實驗數量:佔皮膚病整體比率

在G7各國臨床實驗數量:各階段

在G7各國臨床實驗數量:各進展狀況

在E7各國臨床實驗數量:佔皮膚病整體比率

在E7各國臨床實驗數量:各階段

在E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

在各階段的實驗完成情形

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商種類別臨床實驗量

有潛力的贊助商

  • 參加疤痕增長症治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗的最新趨勢(全4件)

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Renovo Group Plc
    • Sanofi
    • Novartis AG
    • 日本Medical調查
    • MS Clinical Research Pvt Ltd
    • GlaxoSmithKline plc
    • Galena Biopharma, Inc.
    • CATALYSIS, S.L.
  • 有代表性的研究機關·政府機關臨床實驗概要
    • St. Luke's-Roosevelt Hospital Center
    • Center for Genetic Engineering and Biotechnology
    • Keloid Research Foundation
    • University of Connecticut Health Center
    • Carmel Medical Center
    • University of Schleswig-Holstein
    • Northwestern University
    • VU University Medical Center
    • Herlev Hospital

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4687CTIDB

GlobalData's clinical trial report, "Keloids Global Clinical Trials Review, H2, 2017" provides an overview of Keloids clinical trials scenario. This report provides top line data relating to the clinical trials on Keloids. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Keloids to Dermatology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Keloids to Dermatology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Keloids Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 56

  • Abbreviations 56
  • Definitions 56
  • Research Methodology 56
  • Secondary Research 57
  • About GlobalData 57
  • Contact Us 58
  • Source 58

List of Tables

List of Tables

  • Keloids Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Keloids Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Keloids Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Keloids Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Keloids Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Keloids Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Keloids Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Keloids Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Keloids to Dermatology Clinical Trials, G7 Countries (%), 2017* 14
  • Keloids Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Keloids Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Keloids to Dermatology Clinical Trials, E7 Countries (%), 2017* 17
  • Keloids Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Keloids Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Keloids Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Keloids Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Keloids Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Keloids Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Keloids Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Keloids Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Keloids Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Keloids Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Keloids Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

List of Figures

  • Keloids Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Keloids Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Keloids Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Keloids Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Keloids Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Keloids Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Keloids Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
  • Keloids Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Keloids to Dermatology Clinical Trials, G7 Countries (%), 2017* 14
  • Keloids Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Keloids Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Keloids to Dermatology Clinical Trials, E7 Countries (%), 2017* 17
  • Keloids Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Keloids Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Keloids Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Keloids Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Keloids Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Keloids Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Keloids Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Keloids Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Keloids Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Keloids Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Keloids Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
  • GlobalData Methodology 57
Back to Top